Lifeline Biotechnologies Stock Buy Hold or Sell Recommendation
| LLBO Stock | USD 0.0002 0.0001 100.00% |
Given the investment horizon of 90 days and your above-average risk tolerance, our recommendation regarding Lifeline Biotechnologies is 'Strong Sell'. The recommendation algorithm takes into account all of Lifeline Biotechnologies' available fundamental, technical, and predictive indicators you will find on this site.
Check out Lifeline Biotechnologies Analyst Recommendation to compare Macroaxis Buy or Sell Recommendation with the current analyst consensus. To check ratings for multiple equity instruments, please use the Instant Ratings tool. In addition, we conduct extensive research on individual companies such as Lifeline and provide practical buy, sell, or hold advice based on investors' investing horizon and their risk tolerance towards Lifeline Biotechnologies. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of labor statistics.
Lifeline |
Execute Lifeline Biotechnologies Buy or Sell Advice
The Lifeline recommendation should be used to complement the buy-or-sell advice compiled from the current analysts' consensus on Lifeline Biotechnologies. Macroaxis does not own or have any residual interests in Lifeline Biotechnologies or other equities on which the buy-or-sell advice is provided. Please provide your input below to execute Lifeline Biotechnologies' advice using the current market data and latest reported fundamentals.
Time Horizon
Risk Tolerance
 |  |
Strong Sell
Market Performance | Good | Details | |
Volatility | Out of control | Details | |
Hype Condition | Over hyped | Details | |
Current Valuation | Overvalued | Details | |
Odds Of Distress | Low | Details | |
Economic Sensitivity | Moves completely opposite to the market | Details | |
Analyst Consensus | Not Available | Details | |
Reporting Quality (M-Score) | Inapplicable | Details |
Lifeline Biotechnologies Trading Alerts and Improvement Suggestions
| Lifeline Biotechnologies is way too risky over 90 days horizon | |
| Lifeline Biotechnologies has some characteristics of a very speculative penny stock | |
| Lifeline Biotechnologies appears to be risky and price may revert if volatility continues | |
| Net Loss for the year was (574.27 K) with profit before overhead, payroll, taxes, and interest of 0. |
Lifeline Biotechnologies Returns Distribution Density
The distribution of Lifeline Biotechnologies' historical returns is an attempt to chart the uncertainty of Lifeline Biotechnologies' future price movements. The chart of the probability distribution of Lifeline Biotechnologies daily returns describes the distribution of returns around its average expected value. We use Lifeline Biotechnologies price's Value At Risk and its Upside Potential as a relative measure of the distribution. The graph of the distribution of Lifeline Biotechnologies returns is essential to provide solid investment advice for Lifeline Biotechnologies.
| Mean Return | 13.41 | Value At Risk | -66.67 | Potential Upside | 100.00 | Standard Deviation | 50.01 |
Return Density |
| Distribution |
Investment risk management requires an estimate of the probability of extreme price changes. Therefore, the correct representation of the distribution of Lifeline Biotechnologies historical returns presented in an easy-to-digest graphical form helps investors and money managers understand the risk-reward trade-off of different investement strategies.
Lifeline Biotechnologies Greeks
Most traded equities are subject to two types of risk - systematic (i.e., market) and unsystematic (i.e., nonmarket or company-specific) risk. Unsystematic risk is the risk that events specific to Lifeline Biotechnologies or Healthcare sector will adversely affect the stock's price. This type of risk can be diversified away by owning several different stocks in different industries whose stock prices have shown a small correlation to each other. On the other hand, systematic risk is the risk that Lifeline Biotechnologies' price will be affected by overall pink sheet market movements and cannot be diversified away. So, no matter how many positions you have, you cannot eliminate market risk. However, you can measure a Lifeline pink sheet's historical response to market movements and buy it if you are comfortable with its volatility direction. Beta and standard deviation are two commonly used measures to help you make the right decision.
α | Alpha over Dow Jones | 13.40 | |
β | Beta against Dow Jones | -3.79 | |
σ | Overall volatility | 67.44 | |
Ir | Information ratio | 0.20 |
Lifeline Biotechnologies Volatility Alert
Lifeline Biotechnologies is showing large volatility of returns over the selected time horizon. Lifeline Biotechnologies appears to be a penny stock. Although Lifeline Biotechnologies may be, in fact, a solid short-term or long term investment, many penny pink sheets are speculative investment instruments that are often subject to artificial stock promotion and campaigns of hype which may lead to misinformation and misrepresentation. Please make sure you fully understand upside potential and downside risks of investing in Lifeline Biotechnologies or similar risky assets. We encourage investors to look for signals such as email spams, message board hypes, claims of breakthroughs, volume upswing without any event/news,and sudden news releases. We also encourage traders to check biographies and work history of company President, CEO or other officers before investing in high-volatility instruments, penny stocks, or equities with microcap classification. You can indeed make money on Lifeline instrument if you perfectly time your entry and exit. However, remember that penny pink sheets that have been the subject of artificial hype usually unable to maintain their increased share price for more than just a few days. The price of a promoted high volatility instrument will almost always revert back. The only way to increase shareholder value is through legitimate performance backed up by solid fundamentals.Lifeline Biotechnologies Fundamentals Vs Peers
Comparing Lifeline Biotechnologies' fundamentals to the average values of its peers is one of the most widely used and accepted methods of equity analyses. It helps to analyze Lifeline Biotechnologies' direct or indirect competition across all of the common fundamentals between Lifeline Biotechnologies and the related equities. This way, we can detect undervalued stocks with similar characteristics as Lifeline Biotechnologies or determine the pink sheets which would be an excellent addition to an existing portfolio. Peer analysis of Lifeline Biotechnologies' fundamental indicators could also be used in its relative valuation, which is a method of valuing Lifeline Biotechnologies by comparing valuation metrics with those of similar companies.
| Better Than Average | Worse Than Average | Compare Lifeline Biotechnologies to competition |
| Fundamentals | Lifeline Biotechnologies | Peer Average |
| Current Valuation | 4.25 M | 16.62 B |
| Net Income | (574.27 K) | 570.98 M |
| Cash And Equivalents | 603.32 K | 2.7 B |
| Total Debt | 448.07 K | 5.32 B |
| Debt To Equity | 0.08 % | 48.70 % |
| Current Ratio | 8.42 X | 2.16 X |
| Book Value Per Share | 0 X | 1.93 K |
| Number Of Employees | 1 | 18.84 K |
| Beta | -1.86 | -0.15 |
| Market Capitalization | 10.99 M | 19.03 B |
| Total Asset | 6.72 M | 29.47 B |
| Z Score | 14.4 | 8.72 |
| Net Asset | 6.72 M |
Lifeline Biotechnologies Market Momentum
Traders often use several daily momentume indicators to supplement a more traditional technical analysis when analyzing securities such as Lifeline . With many different options, investors must choose the best indicators for them and familiarize themselves with how they work. We suggest combining traditional momentum indicators with more near-term forms of technical analysis such as Accumulation Distribution or Daily Balance Of Power. With their quantitative nature, daily value technical indicators can also be incorporated into your automated trading systems.
| Daily Balance Of Power | 9.2 T | |||
| Rate Of Daily Change | 2.0 | |||
| Day Median Price | 2.0E-4 | |||
| Day Typical Price | 2.0E-4 | |||
| Price Action Indicator | 1.0E-4 | |||
| Period Momentum Indicator | 1.0E-4 |
About Lifeline Biotechnologies Buy or Sell Advice
When is the right time to buy or sell Lifeline Biotechnologies? Buying financial instruments such as Lifeline Pink Sheet isn't very hard. However, what challenging for most investors is doing it at the right time to beat the market. Proper market timing is something most people cannot do without sophisticated tools, which help to isolate the right opportunities. Macroaxis provides hands-on modules to deliver winning trades and diversify your portfolios on a daily basis. Most of our advising modules are very easy to use and apply.
Please read more on our stock advisor page.
Use Investing Ideas to Build Portfolios
In addition to having Lifeline Biotechnologies in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Broad Sovereign ETFs Thematic Idea Now
Broad Sovereign ETFs
ETF themes focus on helping investors to gain exposure to a broad range of assets, diversify, and lower overall costs. The Broad Sovereign ETFs theme has 14 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Broad Sovereign ETFs Theme or any other thematic opportunities.
| View All Next | Launch |
Other Information on Investing in Lifeline Pink Sheet
Lifeline Biotechnologies financial ratios help investors to determine whether Lifeline Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Lifeline with respect to the benefits of owning Lifeline Biotechnologies security.